Phathom Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Phathom Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 64.6M shares, a 13.8% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 51.3M shares, a 31.1% increase from 2022.
  • Phathom Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 39.1M shares, a 5.72% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 64.6M +7.85M +13.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 58.6M +10.1M +20.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 58.4M +16M +37.8% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-06-14
Q4 2023 51.3M +12.2M +31.1% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-06-14
Q3 2023 56.8M +18M +46.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 48.5M +10.2M +26.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 42.4M +4.32M +11.4% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-06-14
Q4 2022 39.1M Oct 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
Q3 2022 38.8M +1.52M +4.08% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 38.3M +1.64M +4.47% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 38M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q3 2021 37.3M Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-09
Q2 2021 36.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.